Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age

被引:119
作者
Fakhoury, M
Litalien, C
Medard, Y
Cave, H
Ezzahir, N
Peuchmaur, M
Jacqz-Aigrain, E
机构
[1] Hop Robert Debre, Dept Paediat Pharmacol & Pharmacogenet, F-75019 Paris, France
[2] Hop Robert Debre, Dept Mol Biol, F-75019 Paris, France
[3] Hop Robert Debre, Clin Epidemiol Unit, F-75019 Paris, France
[4] Hop Robert Debre, Dept Anatomopathol, F-75019 Paris, France
关键词
D O I
10.1124/dmd.105.005611
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochromes P450 3A (CYP3A) and P-glycoprotein (P-gp) are mainly located in enterocytes and hepatocytes. The CYP3A/P-gp system contributes to the first-pass metabolism of many drugs, resulting in a limited bioavailability. During the neonatal period, a shift between CYP3A7, the fetal form, and CYP3A4 occurs in the liver, but data on the expression of the CYP3A/P-gp complex in the intestine are very limited. A total of 59 normal duodenal biopsies from white children aged 1 month to 17 years were studied. Localization of the proteins by immunohistochemistry analysis was performed using a polyclonal antibody, Nuage anti-CYP3A, and a monoclonal antibody, C494 anti-P-gp. The mRNA quantification was performed using highly specific real-time reverse transcription-polymerase chain reaction. Villin mRNA quantification was used for normalization. CYP3A protein was detected in all enterocytes in the samples from patients over 6 months of age, whereas it was not in younger samples. P-gp protein was expressed at the apical and upper lateral surfaces of the enterocytes. CYP3A isoforms and P-gp mRNA levels were highly variable. CYP3A4 and CYP3A5 mRNA levels were high during the first year of life and decreased with age, whereas CYP3A7 was detected at a low level in 64% of samples, whatever the age. P-gp mRNA expression level was also highly variable. Our results showed that neonates and infants had a significant expression of CYP3A and P-gp mRNA in the intestine, suggesting a different maturation profile of CYP3A and P-gp with age in the liver and the intestine.
引用
收藏
页码:1603 / 1607
页数:5
相关论文
共 23 条
[1]   Pharmacogenetics of the human drug-transporter gene MDR1:: impact of polymorphisms on pharmacotherapy [J].
Brinkmann, U ;
Roots, I ;
Eichelbaum, M .
DRUG DISCOVERY TODAY, 2001, 6 (16) :835-839
[2]   Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects [J].
Cascorbi, I ;
Gerloff, T ;
Johne, A ;
Meisel, C ;
Hoffmeyer, S ;
Schwab, M ;
Schaeffeler, E ;
Eichelbaum, M ;
Brinkmann, U ;
Roots, I .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :169-174
[3]   Ontogeny of cytochrome 3A and P-glycoprotein in the human intestine. [J].
Fakhoury, M ;
Litalien, C ;
Medard, Y ;
Peuchmaur, M ;
Jacqz-Aigrain, E .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) :P50-P50
[4]   The genetic determinants of the CYP3A5 polymorphism [J].
Hustert, E ;
Haberl, M ;
Burk, O ;
Wolbold, R ;
He, YQ ;
Klein, K ;
Nuessler, AC ;
Neuhaus, P ;
Klattig, J ;
Eiselt, R ;
Koch, I ;
Zibat, A ;
Brockmöller, J ;
Halpert, JR ;
Zanger, UM ;
Wojnowski, L .
PHARMACOGENETICS, 2001, 11 (09) :773-779
[5]   A comparison of the ontogeny of enterocytic and hepatic cytochromes P450 3A in the rat [J].
Johnson, TN ;
Tanner, MS ;
Tucker, GT .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (11) :1601-1610
[6]   Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis [J].
Johnson, TN ;
Tanner, MS ;
Taylor, CJ ;
Tucker, GT .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (05) :451-460
[7]   Cisapride disposition in neonates and infants: In vivo reflection of cytochrome P450 3A4 ontogeny [J].
Kearns, GL ;
Robinson, PK ;
Wilson, JT ;
Wilson-Costello, D ;
Knight, GR ;
Ward, RM ;
van den Anker, JN .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (04) :312-325
[8]   Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA [J].
Koch, I ;
Weil, R ;
Wolbold, R ;
Brockmöller, J ;
Hustert, E ;
Burk, O ;
Neussler, A ;
Neuhaus, P ;
Eichelbaum, M ;
Zanger, U ;
Wojnowski, L .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (10) :1108-1114
[9]   Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression [J].
Kuehl, P ;
Zhang, J ;
Lin, Y ;
Lamba, J ;
Assem, M ;
Schuetz, J ;
Watkins, PB ;
Daly, A ;
Wrighton, SA ;
Hall, SD ;
Maurel, P ;
Relling, M ;
Brimer, C ;
Yasuda, K ;
Venkataramanan, R ;
Strom, S ;
Thummel, K ;
Boguski, MS ;
Schuetz, E .
NATURE GENETICS, 2001, 27 (04) :383-391
[10]   Expression of CYP3A in the human liver - Evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth [J].
Lacroix, D ;
Sonnier, M ;
Moncion, A ;
Cheron, G ;
Cresteil, T .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 247 (02) :625-634